Israel’s TheraCoat said to seek more than $20 million before IPO| glObserver Global Economics

TheraCoat, a developer of treatments for urinary tract diseases, is seeking to raise additional than $20 million in coming months as it prepares for an initial public offering in New York, people with knowledge of the matter said.


The Israeli company, which says its gel technology allows cancer drugs to stick better to the bladder wall, may be listed on the Nasdaq Stock Market as early as this year, one of the people said, declining to be named as the matter is confidential. The company will seek a valuation of about $200 million in the IPO, the people said.

See on Scoop.itglobserver middle east


Author: globserver

Director of Eyecom china

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s